Next Article in Journal
HIV Drug Resistance Mutations Detection by Next-Generation Sequencing during Antiretroviral Therapy Interruption in China
Previous Article in Journal
Human Papillomavirus and Cellular Pathways: Hits and Targets
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pathogens
Volume 10
Issue 3
10.3390/pathogens10030263
pathogens-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Photodynamic Eradication of Trichophyton rubrum and Candida albicans

by
Anton Valkov
,
Michael Zinigrad
and
Marina Nisnevitch
*
Department of Chemical Engineering, Ariel University, Kiryat-ha-Mada, Ariel 4070000, Israel
*
Author to whom correspondence should be addressed.
Pathogens 2021, 10(3), 263; https://doi.org/10.3390/pathogens10030263
Submission received: 29 January 2021 / Revised: 16 February 2021 / Accepted: 21 February 2021 / Published: 25 February 2021
Browse Figures
Versions Notes

Abstract

:
Conventional methods of onychomycosis treatment are ineffective in some cases because the cure of onychomycosis very often depends on the patient’s individual response to the treatment; therefore, there is a crucial need to research and develop new methods of onychomycosis therapy. One of the most innovative treatments is photodynamic therapy (PDT) using photosensitizers (PSs). However, effective treatment depends on the correct choice of photosensitizer and substances that improve the characteristics of the final formulation. The aim of our work was to find an effective formulation for the treatment of onychomycosis. To achieve this goal, we tested the effect of three types of PSs, rose Bengal (RB), malachite green oxalate (MGO), and methylene blue (MB), on Candida albicans. The most effective PS was RB, and so the study was continued with Trichophyton rubrum. Additional comparative studies were carried out on substances included in the formulation (urea and thiourea), focusing on their antifungal activity, which can improve penetration through the nail plate. The composition of the formulation that achieved 100% eradication of Trichophyton rubrum under our conditions consisted of 150 μM RB, 5% urea, and 0.5% thiourea in glycerol/water (70/30%, w/w) solution. A white luminescent lamp was used as a light source (1.9 ± 0.1 mW cm−2). Stability of the formulation was checked. The selected formulation shows potential for future simplification and acceleration of PDT treatment of onychomycosis.

1. Introduction

Onychomycosis, fungal nail infection, is an acute and persistent problem in public health. Epidemiological studies around the world have found a high incidence of onychomycosis in at least 10–30% of the general population [1,2], in more than 20% of those over 60 years old, in 50% of those over 70 years old, and in 30% of patients with diabetes [3,4].
Onychomycosis is often considered only an aesthetic problem. However, patients having onychomycosis along with a background of immunodeficiency or endocrine diseases may develop widespread mycosis of the skin. Sometimes onychomycosis is accompanied by development of severe complications such as diabetic foot, extremity erysipelas, or lymphostasis. For this reason, onychomycosis treatment is strictly necessary and should be carried out promptly [5,6,7]. Clinical studies have shown that the effectiveness of systemic antimycotics after the end of treatment is 40–80%, and after 5 years only 14–50% [8]. It was proven that the effectiveness of onychomycosis therapy can be increased by applying complex methods of treatment that combine antifungal drugs with agents affecting pathogenesis [9,10].
Advanced methods of onychomycosis therapy include local or oral therapy and surgical intervention [1,11]. However, even when using these complex methods, it is difficult to achieve positive results, since drugs applied topically usually cannot penetrate into the nail plate to the site of infection, but instead are concentrated on its external surface [12]. Moreover, systemic use of antifungal drugs such as ketoconazole, terbinafine, and griseofulvin sometimes needs up to 12 months of treatment [13], and long-term application of these drugs carries a toxicological effect that can harm human health [14,15]. In addition, fungi may develop resistance to antifungal drugs under a long period of exposure. Surgical treatment is very unpopular, since it causes discomfort and pain in patients and is relatively ineffective since it leads to deformation of the treated nail plates and scar formation [16,17].
In recent years, alternate methods of onychomycosis treatment, such as photodynamic therapy (PDT), have been actively developed and tested [18]. PDT is a special field of light therapy. Compounds called photosensitizers (PSs) are applied to an infected site and undergo activation by visible light [19,20]. Illumination leads to production of active radicals, such as reactive oxygen species (ROS), which cause irreversible damage to microorganisms. The ability of PSs to eradicate microorganisms has been described by many authors [21,22,23,24,25,26,27,28]. PSs are effective against bacterial, viral, fungal, and protozoal infections [29].
To enhance the efficiency of PDT, it is necessary to select the PS formulation with optimal consistency in providing high-speed drug penetration into a nail plate. However, although necessary, this parameter is not a sufficient condition for successful local treatment of fungal infections. To assess the effectiveness of onychomycosis treatment with antifungal drugs in various forms (e.g., transfersomes, nanoemulsions, gels, creams, and ointments) and their combinations, with or without the addition of surfactants [30,31], the use of keratin biomembranes was proposed as a good substitute for hard-to-obtain human nails [32,33,34]. The keratin biomembranes have physical properties similar to nail plates and can be obtained with good reproducibility.
This study aimed to find a promising formulation and conditions for effective PDT against fungal infection caused by Candida albicans and Trichophyton rubrum. Three water-soluble PSs were selected for antifungal studies, rose Bengal (RB), malachite green oxalate (MGO), and methylene blue (MB), all of which exhibit high antimicrobial activity [35,36]. These PSs were tested against fungi at different concentrations and in various formulations, with and without keratolytic agents.
An appropriate formulation for photodynamic treatment of onychomycosis should include a photosensitizer and keratolytic agents to increase the permeability of nail plates to active agents. The formulation should also have a viscosity high enough to keep the PS on the nail surface and prevent its leakage to the nail sides. We also examined the stability of the proposed formulations.

2. Results and Discussion

This work focused on a study of antifungal properties of photosensitizers, alone and in combination with factors affecting the permeation of drug molecules into a nail plate. Two fungi known to cause onychomycosis were examined: Candida albicans and Trichophyton rubrum. The former strain was tested in planktonic cultures and the latter on solid media including fabricated keratin membranes that model nail plates.

2.1. Photodynamic Treatment of Planktonic Culture of Candida albicans

First, the chosen PSs (RB, MGO, and MB) were tested on planktonic cultures of Candida albicans using a high concentration (500 µM) of each PS under prolonged illumination. For this purpose, the solutions were distributed into Petri dishes containing Candida albicans suspension and illuminated for 4 h by a white luminescent light. The experiment showed that only MGO and RB caused total eradication of Candida albicans cells, while MB was inactive (Figure 1). In our previous studies, MB showed high photodynamic activity against Gram-positive and Gram-negative bacteria [22,35,37,38,39], however, in the case of fungi, this PS was unable to inhibit cell growth.
Since only two PSs showed antifungal activity, the study was continued using MGO and RB only. At the next stage, their photodynamic activity was tested at different concentrations and during various time periods. The effect of MGO on Candida albicans is shown in Figure 2a. Complete inactivation of Candida albicans was achieved using MGO at 250 μM concentration after 4 h of illumination, compared to 50 μM MGO, which caused only partial cell destruction. Over shorter time periods, even 250 μM MGO decreased the cell concentration only by 0.5–2 log10 values. The activity of RB against Candida albicans is illustrated in Figure 2b. The cells were completely eradicated at concentrations of both 50 and 250 μM RB after 30 min of illumination, i.e., RB showed a significantly higher ability in fungal cell eradication than did MGO.
Next, it was proven that the cells were eradicated by RB due to illumination. For this purpose, the photodynamic activity of RB against Candida albicans was compared to the same process in darkness. The results in Figure 3 show that under illumination, 50 μM RB totally eradicated Candida albicans within 15 min, whereas in the dark, even after 30 min the fungi cell concentration did not differ from that in the control series. Previously, the photodynamic effect of RB on planktonic cultures of Candida albicans was demonstrated by Costa et al. [40] and Freire et al. [41]. Costa et al. achieved a 1.58 log10 reduction in cell concentration under treatment with 5 μM RB, using a blue LED light at 455 ± 20 nm at the fluence rate of 526 mW/cm2 and illumination for 180 s, which supplied an energy dose of 95 J/cm2. Freire et al. used 12.5 μM RB under a green LED light at 532 ± 10 nm at a fluence rate of 237 mW/cm2 and the same illumination time (energy dose 42.6 J/cm2), thereby achieving complete cell eradication. In our study, complete cell eradication was obtained at a higher RB concentration (50 μM) but at much lower light fluence (2.0 mW/cm2). In our experiments, using 50 μM RB illuminated by a white wide-spectrum lamp supplying an energy dose of only 1.7 J/cm2 enabled the complete inhibition of Candida albicans growth.

2.2. Photodynamic Treatment of Trichophyton rubrum

In this part of the study, we tested two prospective photosensitizers, MGO and RB, against the fungus Trichophyton rubrum. In addition, we examined the antifungal effect of two common keratolytic agents, urea and thiourea [42]. Solutions of the agents were prepared in a water base or a glycerol/water (70/30%, w/w) mixture. First, we studied the photodynamic effects of RB and MGO in aqueous solutions at various concentrations (Figure 4 and Figure 5, respectively). Figure 4a,b show the effect of RB on the cells of Trichophyton rubrum under illumination and in the dark, respectively. The layout of wells in the experiment is shown in Figure 4c. Complete inhibition of Trichophyton rubrum growth was achieved in the presence of 50 μM RB under illumination (Figure 4a). RB had no effect on Trichophyton rubrum in the dark.
It is worth mentioning that the cells of Candida albicans were also inhibited by RB at this concentration (Figure 2b). In the work of Houang et al. [43], it was shown that RB at the concentration of 140 μM can kill virtually all (99.99 ± 0.01%) spores of Trichophyton rubrum under irradiation by a 532 nm laser at 40 mW for 10 min (101 J/cm2 fluence). In clinical studies, RB was applied at the concentration of 140 μM under laser irradiation at 2.55 W/cm2 against toenail onychomycosis in vivo and after 5 treatments for 3 months complete clinical and mycological clearance was achieved [44].
A similar experiment was performed using MGO, and the results showed that this PS also totally inhibited the growth of Trichophyton rubrum at 50 μM, but unlike RB, there was no difference between the results obtained under illumination and in the dark (Figure 5a,b, respectively). Figure 5c presents the layout of wells in this experiment. Since the effect of MGO on fungal cells could not be assigned to its photodynamic activity, the study was continued using only RB as a PS.
Two agents known to enhance the permeability of nails, urea and thiourea [42,45], were tested for antifungal activity as well. The experiments were performed as in the case of the PSs. Figure 6 and Figure 7 show the antifungal effects of thiourea and urea, respectively, when applied in aqueous solutions to agar medium with pre-seeded fungi.
The results showed that thiourea exhibited strong antifungal effects at concentrations above 3% (Figure 6), while urea totally inhibited the growth of Trichophyton rubrum at concentrations of above 25% (Figure 7). Previous in vivo studies showed contradictory data on the antifungal effect of urea. Bunyaratavej at al. [46] reported a partial (32%) cure of onychomycosis when using a cream containing 40% urea. However, Escalante et al. [47] found that application of the same 40% urea cream led to an onychomycosis mycological cure in 8.3% of cases.
At the next stage of our study, we tested the antifungal activity of RB, a mixture of urea and thiourea, and a mixture of RB, urea and thiourea in a glycerol/water solution. Figure 8 shows the effect of RB in a glycerol/water mixture on Trichophyton rubrum. Fungal growth was totally inhibited at RB concentrations above 200 μM. Although it is not seen distinctly in the photograph in Figure 8a, at concentrations of 50 and 100 μM there was a proliferation of fungal cells.
It should be mentioned that this inhibitory concentration of 200 μM is much higher than that of RB in an aqueous solution (50 μM). We assume that such a difference between these results may be due to the different amounts of dissolved oxygen in the solutions. Oxygen solubility decreases linearly with an increase of glycerol fraction in glycerol/water mixtures [48], so the oxygen concentration may be insufficient for providing effective photodynamic activity of PSs acting according to the Type II mechanism. This mechanism involves energy transfer from a PS in a triplet excited state (3PS*) to dissolved molecular oxygen in a triplet ground state (3O2), leading to a formation of oxygen in a singlet excited state (1O2), which causes irreversible damage to microorganisms [49,50].
After determining the concentrations of thiourea and urea in aqueous solution that inhibit growth of Trichophyton rubrum, the antifungal effects of their mixture in a glycerol/water solution was tested. Since urea and thiourea inhibited Trichophyton rubrum at concentrations of 25% and 3%, respectively, which is an approximate ratio of 10:1, this ratio was chosen as a baseline for all dilutions in this experiment. The results are presented in Figure 9. Interestingly, upon mixing urea and thiourea, the inhibiting of fungal growth occurred at much lower concentrations of these components than when applying each of them separately. The same inhibitory effects on Trichophyton rubrum obtained at the above-mentioned concentrations of urea and thiourea when applied separately (25% and 3%, respectively) was achieved by their mixture at concentrations of only 10% and 1%, respectively (Figure 9). The results obtained in the dark were identical to those obtained under illumination (data not shown). It appears that the mixture caused a synergistic antifungal effect despite the addition of glycerol to the solution.
Finally, we tested a formulation containing all three successful compounds (RB, urea, and thiourea) in glycerol/water (70/30%, w/w) solutions at various concentrations, with Trichophyton rubrum, under illumination and in the dark. Figure 10 shows the results of this experiment. Under illumination, total inhibition of fungal growth was observed in the formulation containing 150 μM RB, 5% urea, and 0.5% thiourea (Figure 10a). Figure 10b shows that without illumination the formulation rendered no antifungal effect. The mixture of urea and thiourea at the concentrations applied in this experiment did not inhibit Trichophyton rubrum, and the inhibiting concentration of RB in this formulation was lower than when RB was applied alone. Therefore, the presence of urea and thiourea even in sub-inhibiting concentrations contributed to the overall antifungal effect.

2.3. Stability of Formulations

To examine the stability of the selected antifungal formulation over time, eight solutions, containing each component alone or a mixture of all three components in aqueous and glycerol/water solutions (Table 1), were prepared at the same concentrations of stock solutions used for the photodynamic experiments described above. The solutions were incubated under shaking in the dark and monitored by measuring their UV/Vis spectra over time. The monitoring of the solutions was performed at wavelengths of maximal absorption, λmax (Table 1). With regard to the four water-based and three glycerol/water solutions (samples 1–4 and 6–8 in Table 1, respectively), no changes in their spectra were observed during 32 days of monitoring; therefore, it was concluded that these samples were stable over time. However, the spectrum of the urea solution in the glycerol/water mixture (sample 5 in Table 1) changed after the 32-day incubation, displaying a new peak at 272 nm (Figure 11a), probably due to decomposition of the urea. Since the antifungal formulation suggested as optimal contains all three compounds (urea, thiourea, and RB) in the glycerol/water mixture, we assume that urea may decompose in this formulation as well. Nevertheless, its spectra (sample 8, Figure 11b) did not register any additional peak, or even a shoulder, in the region of 250–300 nm. Therefore, we concluded that this formulation demonstrates good overall stability.
We assume that in vivo experiments will show the suggested formulation to be efficient against onychomycosis. Moreover, using an ordinary white luminescent lamp as proposed here contrasts with most studies on photodynamic inhibition of fungi, where excitation of PSs is performed by lasers at specific wavelengths. This difference should simplify future applications of our suggested formulation for onychomycosis treatment in everyday environments.
To complete the determination of optimal conditions of the treatment, our group is currently carrying out studies on PS permeation into keratin biomembranes that model nail plates. These studies are attempting to test the effect of the keratolytic agents (urea and thiourea) on delivery of PSs into the nail plate.

3. Materials and Methods

3.1. Fungal Strains

Two fungal strains Candida albicans (ATCC 90028) and Trichophyton rubrum (ATCC MYA-4438) were used in this study.

3.2. Preparation and Growth of Fungi

Candida albicans was seeded onto DifcoTM Yeast Mold (YM) agar (BD, Franklin Lakes, NJ, USA) and incubated for 48 h at 30 °C; 2–3 colonies of yeast were seeded into DifcoTM YM broth (BD) and incubated under shaking at 200 rpm for 24 h at 30°C. The obtained inoculum was diluted with saline (0.90% w/v of NaCl) to obtain a suspension having OD530 = 0.10–0.16. This OD was measured using a spectrophotometer (Genesys 10S UV-VIS, Thermo Fisher, Waltham, MA, USA), and its value corresponded to cell concentration of 1–3 × 106 cells/ml according to the 0.5 McFarland standard method [51].
Trichophyton rubrum was grown for 14 days on YM agar at 30 °C. Samples of 0.5 cm2 of dermatophyte culture were cut off from the agar plates with a scalpel, suspended in 10 mL of YM broth and incubated under shaking at 200 rpm for 48 h at 30 °C. The obtained suspensions were filtered through a sterile cotton gauze pad, which retained hyphal fragments but permitted the passage of dermatophyte microconidia.

3.3. Photodynamic Treatment of Planktonic Cultures of Candida albicans

Stock solutions of RB, MGO, and MB hydrate (Sigma-Aldrich, St. Louis, MO, USA) in water were prepared at the concentration of 4.5 mM. Aliquots of the stock solutions were added to 10 mL of Candida albicans suspension at the concentration of 2–8 × 106 cells/mL in a Petri dish, to achieve a final PS concentration of 500 μM. In some experiments, RB and MGO solutions were added to 10 mL of Candida albicans suspension to obtain final concentrations of 50, 250, or 500 μM. The cell suspensions with MB were exposed to light for 4 h, and samples with RB and MGO were exposed for 0.5, 1, 2, 3, and 4 h, using an 18 W white luminescent lamp with an emissions range of 400–700 nm, providing a light intensity of 1.9 ± 0.1 mW/cm2 at ambient temperature. Illuminance was measured by a LX-102 light meter (Lutron, Taipei, Taiwan). After irradiation, 100 μL aliquots of each sample in 3–4 decimal dilutions were spread over YM agar plates with a Drigalsky spreader, incubated at 37 °C overnight, and then the colony-forming units (CFU) were counted. These experiments aimed to test the photodynamic character of the PS activity compared to activity without exposure to light. In the control experiments, samples of Candida albicans suspension without addition of PS were used.

3.4. Photodynamic Treatment of Trichophyton rubrum

The schematic presentation of experiments in the photodynamic treatment of Trichophyton rubrum is shown in Scheme 1. First, 2 mL portions of YM agar were dispensed into each well of a 12-well plate. After hardening of the agar medium, 100 µL aliquots of Trichophyton rubrum suspension were added on the surface. After that, 100 µL of PS solutions, in water or in a glycerol/water (70/30%, w/w) mixture, were applied to the surface after two-fold dilutions. In the case of water solutions, the final concentration in those added onto the agar surface ranged between 800 to 3.12 µM for RB, 200 to 0.78 µM for MGO, 25% to 5% (w/v) for urea, and 7% to 0.06% (w/v) for thiourea. In the case of glycerol/water solutions, the final concentration on the agar surface ranged between 800 to 3.12 µM for RB, and 20/2% to 0.078/0.008% (w/v) for urea/thiourea. The concentration in the three-component formulation (RB/urea/thiourea) was between 150 µM/5%/0.5% and 0.6 µM/0.02%/0.002% (w/v), respectively.
After addition of Trichophyton rubrum suspensions and the solutions of components specified above, the 12-well plate was illuminated for 30 min with a white luminescent lamp at the light fluence of 1.9 ± 0.1 mW/cm2. All experiments were performed at ambient temperature. After illumination, the plates were incubated in the dark at 30 °C for 7 days and examined visually for fungal growth. The same experiments were carried out in parallel without light exposure, and all experiments were duplicated.

3.5. Stability of Formulations

Two solvents were used to prepare eight solutions; four of them were water-based (samples 1–4) and four were based on a glycerol/water (70/30%, w/w) mixture (samples 5–8). Table 1 presents the prepared solutions, containing 0.1 g of each compound (urea, thiourea, or RB, and the three compounds together) dissolved in 10 mL of each solvent. All the solutions were incubated under shaking at 200 rpm for 32 days at 30 °C in the dark. Aliquots of 100 µL from each solution were sampled at the beginning of the experiment, and after 4, 7, and 32 days of incubation. Before examination, the samples were diluted with water, and their spectra were then registered using a 1 cm quartz cuvette in the range of 190–1100 nm with steps of 2 nm. Further monitoring of the solutions was performed at wavelengths of maximal absorption λmax (Table 1).

3.6. Statistical Methods

Each experiment was carried out in duplicate and then repeated to confirm the reproducibility of results. The average value ± SD was calculated.

4. Conclusions

Three photosensitizers, RB, MB, and MGO, were tested for antifungal activity, but only RB was active against Trichophyton rubrum and Candida albicans under illumination. To find a formulation suitable for onychomycosis treatment, urea and thiourea were added to RB as factors for potential enhancement of nail plate permeability. The most effective formulation for inhibiting fungal growth contained 150 μM RB, 5% urea, and 0.5% thiourea in a glycerol/water (70/30%, w/w) solution. The formulation was stable for at least one month of storage at 30 °C.

Author Contributions

Conceptualization, M.N.; methodology, M.N. and A.V.; investigation, A.V.; resources, M.N. and M.Z.; data curation, A.V.; writing—original draft preparation, A.V.; writing—review and editing, M.N. and M.Z.; supervision, M.N. and M.Z.; project administration, M.N. and M.Z.; funding acquisition, M.N. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Research Authority of the Ariel University, Israel (Grant RA1700000353).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data is contained within the article.

Acknowledgments

We acknowledge the Research Authority of the Ariel University, Israel, for supporting this research.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Elewski, B.E.; Hay, R.J. Update on the management of onychomycosis: Highlights on the Third Annual International Summit on Cutaneous Antifungal Therapy. Clin. Infect. Dis. 1996, 23, 305–313. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Burzykowski, T.; Molenberghs, G.; Abeck, D.; Haneke, E.; Hay, R.; Katsambas, A.; Roseeuw, D.; Kerkhof, P.; Aelst, R.; Marynissen, G. High prevalence of foot diseases in Europe: Results of the Achilles Project. Mycoses 2003, 46, 496–505. [Google Scholar] [CrossRef] [PubMed]
  3. Levy, L.A. Epidemiology of onychomycosis in special-risk populations. J. Am. Podiatr. Med. Assoc. 1997, 87, 546–550. [Google Scholar] [CrossRef] [PubMed]
  4. Elewski, B.E. Once-weekly fluconazole in the treatment of onychomycosis: Introduction. J. Am. Acad. Dermatol. 1998, 38, S73–S76. [Google Scholar] [CrossRef]
  5. Rich, P. Special patient populations: Onychomycosis in the diabetic patient. J. Am. Acad. Dermatol. 1996, 35, 10–12. [Google Scholar] [CrossRef]
  6. Yosipovitch, G.; Hodak, E.; Vardi, P.; Shraga, I.; Karp, M.; Sprecher, E.; David, M. The Prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications. Diabetes Care 1998, 21, 506–509. [Google Scholar] [CrossRef] [PubMed]
  7. Cribier, B.J.; Bakshi, R. Terbinafine in the treatment of onychomycosis: A review of its efficacy in high-risk populations and in patients with nondermatophyte infections. Br. J. Dermatol. 2004, 150, 414–420. [Google Scholar] [CrossRef]
  8. Gupta, A.K.; Ryder, J.E.; Johnson, A.M. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis. Br. J. Dermatol. 2004, 150, 537–544. [Google Scholar] [CrossRef]
  9. Angelo, T.; Borgheti-Cardoso, L.N.; Gelfuso, G.M.; Taveira, S.F.; Gratieri, T. Chemical and physical strategies in onychomycosis topical treatment: A review. Med. Mycol. 2016, 55, 461–475. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Liang, Y.; Lu, L.M.; Chen, Y.; Lin, Y.K. Photodynamic therapy as an antifungal treatment. Exp. Ther. Me. 2016, 12, 23–27. [Google Scholar] [CrossRef]
  11. Cohen, P.R.; Scher, R.K. Topical and surgical treatment of onychomycosis. J. Am. Acad. Dermatol. 1994, 31, S74–S77. [Google Scholar] [CrossRef]
  12. Elewski, B.E. Onychomycosis: Pathogenesis, diagnosis, and management (Review). Clin. Microbiol. Rev. 1998, 11, 415–429. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Odom, R.B. New therapies for onychomycosis. J. Am. Acad. Dermatol. 1996, 35, S26–S30. [Google Scholar] [CrossRef]
  14. Katz, H.I. Possible drug interactions in oral treatment of onychomycosis. J. Am. Podiatr. Med. Assoc. 1997, 87, 571–574. [Google Scholar] [CrossRef] [PubMed]
  15. Hay, R.J. New developments in antifungals. Int. J. Dermatol. 1999, 38, 65–69. [Google Scholar] [PubMed]
  16. Tom, C.M.; Kane, M.P. Management of toenail onychomycosis. Am. J. Heal. Pharm. 1999, 56, 865–871. [Google Scholar] [CrossRef] [PubMed]
  17. Nahabedian, M.Y. Multiple-Digit Onychomycosis: A Simple Surgical Cure. Ann. Plast. Surg. 2000, 45, 446–450. [Google Scholar] [CrossRef] [PubMed]
  18. Braathen, L.R.; Morton, C.A.; Basset-Seguin, N.; Bissonnette, R.; Gerritsen, M.J.P.; Gilaberte, Y.; Calzavara-Pinton, P.; Sidoroff, A.; Wulf, H.C.; Szeimies, R.M. Photodynamic therapy for skin field cancerization: An international consensus. International Society for Photodynamic Therapy in Dermatology. J. Eur. Acad. Dermatol. Venereol. 2012, 26, 1063–1066. [Google Scholar] [CrossRef]
  19. Dai, T.; Fuchs, B.B.; Coleman, J.J.; Prates, R.A.; Astrakas, C.; Denis, T.G.S.; Ribeiro, M.S.; Mylonakis, E.; Hamblin, M.R.; Tegos, G.P. Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform. Front. Microbiol. 2012, 3, 1–16. [Google Scholar] [CrossRef] [Green Version]
  20. Allison, R.R.; Moghissi, K. Photodynamic therapy (PDT): PDT mechanisms. Clin. Endosc. 2013, 46, 24–29. [Google Scholar] [CrossRef] [PubMed]
  21. Valkov, A.; Nakonechny, F.; Nisnevitch, M. Antibacterial properties of Rose Bengal immobilized in polymer supports. Appl. Mech. Mater. 2015, 719–720, 21–24. [Google Scholar] [CrossRef]
  22. Valkov, A.; Raik, K.A.; Mualem-Sinai, Y.; Nakonechny, F.; Nisnevitch, M. Water disinfection by immobilized photosensitizers. Water 2018, 11, 1–11. [Google Scholar] [CrossRef] [Green Version]
  23. Ilizirov, Y.; Formanovsky, A.; Mikhura, I.; Paitan, Y.; Nakonechny, F.; Nisnevitch, M. Effect of photodynamic antibacterial chemotherapy combined with antibiotics on Gram-positive and Gram-negative bacteria. Molecules 2018, 23, 3152. [Google Scholar] [CrossRef] [Green Version]
  24. Jin, X.; Xu, H.; Deng, J.; Dan, H.; Ji, P.; Chen, Q.; Zeng, X. Photodynamic therapy for oral potentially malignant disorders. Photodiagnosis Photodyn. Ther. 2019, 28, 146–152. [Google Scholar] [CrossRef] [PubMed]
  25. Nakonechny, F.; Nisnevitch, M. Aspects of photodynamic inactivation of bacteria. In Microorganisms; Blumenberg, M., Ed.; InTech Open Access Publisher: Rijeka, Croatia, 2019; Volume 7, pp. 131–151. [Google Scholar]
  26. Nguyen, K.; Khachemoune, A. An update on topical photodynamic therapy for clinical dermatologists. J. Dermatolog. Treat. 2019, 30, 732–744. [Google Scholar] [CrossRef]
  27. Pertiwi, Y.D.; Chikama, T.; Sueoka, K.; Ko, J.; Kiuchi, Y.; Onodera, M.; Sakaguchi, T. Photodynamic antimicrobial chemotherapy with the photosensitizer TONS504 eradicates Acanthamoeba. Photodiagnosis Photodyn. Ther. 2019, 28, 166–171. [Google Scholar] [CrossRef] [PubMed]
  28. Bokan, M.; Nakonechny, F.; Talalai, E.; Kobzev, D.; Gellerman, G.; Patsenker, L. Photodynamic effect of novel hexa-iodinated quinono-cyanine dye on Staphylococcus aureus. Photodiagnosis Photodyn. Ther. 2020, 31, 1–8. [Google Scholar] [CrossRef] [PubMed]
  29. Hamblin, M.R.; Hasan, T. Photodynamic therapy: A new antimicrobial approach to infectious disease? Photochem. Photobiol. Sci. 2004, 3, 436–450. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  30. Ghannoum, M.; Isham, N.; Herbert, J.; Henry, W.; Yurdakul, S. Activity of TDT 067 (terbinafine in transfersome) against agents of onychomycosis, as determined by minimum inhibitory and fungicidal concentrations. J. Clin. Microbiol. 2011, 49, 1716–1720. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  31. Gupta, A.K.; Simpson, F.C. New therapeutic options for onychomycosis. Expert Opin. Pharmacother. 2012, 13, 1131–1142. [Google Scholar] [CrossRef]
  32. Lusiana; Reichl, S.; Müller-Goymann, C.C. Keratin film made of human hair as a nail plate model for studying drug permeation. Eur. J. Pharm. Biopharm. 2011, 78, 432–440. [Google Scholar] [CrossRef]
  33. Lusiana; Reichl, S.; Müller-Goymann, C.C. Infected nail plate model made of human hair keratin for evaluating the efficacy of different topical antifungal formulations against Trichophyton rubrum in vitro. Eur. J. Pharm. Biopharm. 2013, 84, 599–605. [Google Scholar] [CrossRef]
  34. Valkov, A.; Zinigrad, M.; Sobolev, A.; Nisnevitch, M. Keratin biomembranes as a model for studying onychomycosis. Int. J. Mol. Sci. 2020, 21, 3512. [Google Scholar] [CrossRef]
  35. Nisnevitch, M.; Nakonechny, F.; Nitzan, Y. Photodynamic antimicrobial chemotherapy by liposome-encapsulated water-soluble photosensitizers. Russ. J. Bioorganic Chem. 2010, 36, 363–369. [Google Scholar] [CrossRef] [PubMed]
  36. Prates, R.A.; Yamada, A.M., Jr.; Suzuki, L.C.; Hashimoto, M.C.E.; Cai, S.; Gouw-Soares, S.; Gomes, L.; Ribeiro, M.S. Bactericidal effect of malachite green and red laser on Actinobacillus actinomycetemcomitans. J. Photochem. Photobiol. B 2007, 86, 70–76. [Google Scholar] [CrossRef] [PubMed]
  37. Nisnevitch, M.; Nakonechny, F.; Firer, M.; Nitzan, Y. Photodynamic antimicrobial chemotherapy with photosensitizers in liposomes under external and chemoluminescent excitation. FEBS J. 2009, 276 S1, 332. [Google Scholar]
  38. Nakonechny, F.; Nisnevitch, M.; Nitzan, Y. Antimicrobial properties of photosensitizers methylene blue and neutral red encapsulated in liposomes. FEBS J. 2009, 276, 330–331. [Google Scholar]
  39. Valkov, A.; Nakonechny, F.; Nisnevitch, M. Polymer-immobilized photosensitizers for continuous eradication of bacteria. Int. J. Mol. Sci. 2014, 15, 14984–14996. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  40. Costa, A.C.B.P.; Rasteiro, V.M.C.; Pereira, C.A.; Rossoni, R.D.; Junqueira, J.C.; Jorge, A.O.C. The effects of rose bengal- and erythrosine-mediated photodynamic therapy on Candida albicans. Mycoses 2011, 55, 56–63. [Google Scholar] [CrossRef] [PubMed]
  41. Freire, F.; Costa, A.; Pereira, C.; Junior, M.; Junqueira, J.; Jorge, A. Comparison of the effect of rose bengal- and eosin Y-mediated photodynamic inactivation on planktonic cells and biofilms of Candida albicans. Lasers Med. Sci. 2014, 29, 949–955. [Google Scholar] [CrossRef] [PubMed]
  42. Khan, A.D.; Giri, A.; Singh, L. Transungual drug delivery: A newer approach. World J. Pharm. Pharm. Sci. 2014, 3, 781–794. [Google Scholar]
  43. Houang, J.; Halliday, C.; Chen, S.; Ho, C.-H.; Bekmukhametova, A.; Lauto, A. Effective photodynamic treatment of Trichophyton species with Rose Bengal. J. Biophotonics. 2020, 14, 1–7. [Google Scholar] [CrossRef]
  44. Houang, J.; Perrone, G.G.; Pedrinazzi, C.; Longo, L.; Mawad, D.; Boughton, P.C.; Ruys, A.J.; Lauto, A. Genetic tolerance to Rose Bengal photodynamic therapy and antifungal clinical application for onychomycosis. Adv. Ther. 2019, 2, 1–13. [Google Scholar] [CrossRef]
  45. Quintanar-Guerrero, D.; Ganem-Quintanar, A.; Tapia-Olguín, P.; Kalia, Y.N.; Buri, P. The effect of keratolytic agents on the permeability of three imidazole antimycotic drugs through the human nail. Drug Dev. Ind. Pharm. 1998, 24, 685–690. [Google Scholar] [CrossRef]
  46. Bunyaratavej, S.; Leeyaphan, C.; Rujitharanawong, C.; Surawan, T.; Muanprasat, C.; Matthapan, L. Efficacy of 5% amorolfine nail lacquer in Neoscytalidium dimidiatum onychomycosis. J. Dermatolog. Treat. 2016, 27, 359–363. [Google Scholar] [CrossRef]
  47. Escalante, K.; Herrera, E.O.M.; Torres-Guerrero, E.; Arroyo, S.; Arenas, R. Onychomycosis with dermatophytoma. A comparison among the results of treatments with oral terbinafine, topical 40% urea in monotherapy and combination therapy. Dermatologia Klin. 2013, 15, 67–70. [Google Scholar]
  48. Clever, H.L.; Battino, R.; Miyamoto, H.; Yampolski, Y.; Young, C.L. IUPAC-NIST Solubility Data Series. 103. Oxygen and ozone in water, aqueous solutions, and organic liquids (Supplement to Solubility Data Series Volume 7). J. Phys. Chem. 2014, 43, 1–209. [Google Scholar]
  49. Foote, C.S. Type I and Type II Mechanisms of Photodynamic Action. Am. Chem. Soc. 1987, 339, 22–38. [Google Scholar]
  50. Macdonald, I.J.; Douherty, T.J. Basic principles of photodynamic therapy. J. Porphyr. Phthalocyanines 2001, 5, 105–129. [Google Scholar] [CrossRef]
  51. Pfaller, M.A.; Chaturvedi, V.; Espinel-Ingroff, A.; Ghannoum, M.A.; Gosey, L.L.; Odds, F.C.; Rex, J.H.; Rinaldi, M.G.; Sheehan, D.J.; Walsh, T.J.; et al. Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved Standard—Second Edition. NCCLS Doc. M27-A2 2002, 22, 1–29. [Google Scholar]
Pathogens 10 00263 g001 550
Figure 1. The effect of malachite green oxalate (MGO), rose Bengal (RB) and methylene blue (MB) at 500 μM concentration on planktonic cultures of Candida albicans under white-light illumination at 1.9 ± 0.1 mW/cm2 fluence for 4 h.
Figure 1. The effect of malachite green oxalate (MGO), rose Bengal (RB) and methylene blue (MB) at 500 μM concentration on planktonic cultures of Candida albicans under white-light illumination at 1.9 ± 0.1 mW/cm2 fluence for 4 h.
Pathogens 10 00263 g001
Pathogens 10 00263 g002 550
Figure 2. Effect of 50 and 250 μM of (a) MGO and (b) RB on planktonic culture of Candida albicans under white-light illumination at the fluence of 1.9 ± 0.1 mW/cm2.
Figure 2. Effect of 50 and 250 μM of (a) MGO and (b) RB on planktonic culture of Candida albicans under white-light illumination at the fluence of 1.9 ± 0.1 mW/cm2.
Pathogens 10 00263 g002
Pathogens 10 00263 g003 550
Figure 3. Treatment of Candida albicans planktonic culture by 50 μM RB under white-light illumination at the fluence of 1.9 ± 0.1 mW/cm−2 (L) and in the dark (D).
Figure 3. Treatment of Candida albicans planktonic culture by 50 μM RB under white-light illumination at the fluence of 1.9 ± 0.1 mW/cm−2 (L) and in the dark (D).
Pathogens 10 00263 g003
Pathogens 10 00263 g004 550
Figure 4. Effect of aqueous solutions of RB at various concentrations on growth of Trichophyton rubrum on Yeast Mold (YM) agar: (a) under illumination of 1.9 ± 0.1 mW/cm2 for 30 min and (b) in the dark. The layout of wells in the experiment (c): control wells A1 and B1—untreated culture of Trichophyton rubrum; control C1—agar medium without fungal culture; the remaining wells—agar medium with applied aqueous solutions of RB at concentrations specified in the scheme.
Figure 4. Effect of aqueous solutions of RB at various concentrations on growth of Trichophyton rubrum on Yeast Mold (YM) agar: (a) under illumination of 1.9 ± 0.1 mW/cm2 for 30 min and (b) in the dark. The layout of wells in the experiment (c): control wells A1 and B1—untreated culture of Trichophyton rubrum; control C1—agar medium without fungal culture; the remaining wells—agar medium with applied aqueous solutions of RB at concentrations specified in the scheme.
Pathogens 10 00263 g004
Pathogens 10 00263 g005 550
Figure 5. Effect of aqueous solutions of MGO at various concentrations on growth of Trichophyton rubrum on YM agar: (a) under illumination of 1.9 ± 0.1 mW/cm2 for 30 min and (b) in the dark. The layout of wells in the experiment (c): control wells A1 and B1—untreated culture of Trichophyton rubrum; control C1—agar medium without fungal culture; the remaining wells—agar medium with applied aqueous solutions of MGO at concentrations specified in the scheme.
Figure 5. Effect of aqueous solutions of MGO at various concentrations on growth of Trichophyton rubrum on YM agar: (a) under illumination of 1.9 ± 0.1 mW/cm2 for 30 min and (b) in the dark. The layout of wells in the experiment (c): control wells A1 and B1—untreated culture of Trichophyton rubrum; control C1—agar medium without fungal culture; the remaining wells—agar medium with applied aqueous solutions of MGO at concentrations specified in the scheme.
Pathogens 10 00263 g005
Pathogens 10 00263 g006 550
Figure 6. Effect of thiourea at various concentrations on growth of Trichophyton rubrum on YM agar medium (a). A layout of wells (b) containing aqueous solutions of thiourea applied to agar medium at concentrations specified in the scheme (%, w/v). Control wells contained no thiourea. The experiment was performed under illumination of 1.9 ± 0.1 mW cm−2 for 30 min.
Figure 6. Effect of thiourea at various concentrations on growth of Trichophyton rubrum on YM agar medium (a). A layout of wells (b) containing aqueous solutions of thiourea applied to agar medium at concentrations specified in the scheme (%, w/v). Control wells contained no thiourea. The experiment was performed under illumination of 1.9 ± 0.1 mW cm−2 for 30 min.
Pathogens 10 00263 g006
Pathogens 10 00263 g007 550
Figure 7. Effect of urea at various concentrations on growth of Trichophyton rubrum on YM agar medium (a). A layout of wells (b) containing aqueous solutions of thiourea applied to agar medium at concentrations specified in the scheme (%, w/v). Control wells contained no urea. The experiment was performed under illumination of 1.9 ± 0.1 mW/cm2 for 30 min.
Figure 7. Effect of urea at various concentrations on growth of Trichophyton rubrum on YM agar medium (a). A layout of wells (b) containing aqueous solutions of thiourea applied to agar medium at concentrations specified in the scheme (%, w/v). Control wells contained no urea. The experiment was performed under illumination of 1.9 ± 0.1 mW/cm2 for 30 min.
Pathogens 10 00263 g007
Pathogens 10 00263 g008 550
Figure 8. Effect of glycerol/water (70/30%, w/w) solutions of RB at various concentrations on growth of Trichophyton rubrum on YM agar, (a) under illumination of 1.9 ± 0.1 mW/cm2 for 30 min. A layout of wells (b): control wells A1, B1, and C1—untreated culture of Trichophyton rubrum; the remainder—agar medium with applied glycerol/water solutions of RB at concentrations specified in the scheme.
Figure 8. Effect of glycerol/water (70/30%, w/w) solutions of RB at various concentrations on growth of Trichophyton rubrum on YM agar, (a) under illumination of 1.9 ± 0.1 mW/cm2 for 30 min. A layout of wells (b): control wells A1, B1, and C1—untreated culture of Trichophyton rubrum; the remainder—agar medium with applied glycerol/water solutions of RB at concentrations specified in the scheme.
Pathogens 10 00263 g008
Pathogens 10 00263 g009 550
Figure 9. Effect of urea/thiourea in various concentrations on growth of Trichophyton rubrum on YM agar medium (a). Layout of wells (b) containing glycerol/water (70/30%, w/w) solutions of urea/thiourea applied onto agar medium at concentrations specified in the scheme (%, w/v). Control wells contained no urea/thiourea. The experiment was performed under illumination of 1.9 ± 0.1 mW/cm2 for 30 min.
Figure 9. Effect of urea/thiourea in various concentrations on growth of Trichophyton rubrum on YM agar medium (a). Layout of wells (b) containing glycerol/water (70/30%, w/w) solutions of urea/thiourea applied onto agar medium at concentrations specified in the scheme (%, w/v). Control wells contained no urea/thiourea. The experiment was performed under illumination of 1.9 ± 0.1 mW/cm2 for 30 min.
Pathogens 10 00263 g009
Pathogens 10 00263 g010 550
Figure 10. Effect of RB, urea, and thiourea at various concentrations in glycerol/water (70/30%, w/w) solutions on the growth of Trichophyton rubrum on YM agar: (a) under illumination at 1.9 ± 0.1 mW/cm2 for 30 min and (b) in the dark. A layout of wells (c): control wells A1, B1, and C1—untreated culture of Trichophyton rubrum; the remainder—agar medium with applied glycerol/water solutions of RB, urea, and thiourea at concentrations specified in the scheme.
Figure 10. Effect of RB, urea, and thiourea at various concentrations in glycerol/water (70/30%, w/w) solutions on the growth of Trichophyton rubrum on YM agar: (a) under illumination at 1.9 ± 0.1 mW/cm2 for 30 min and (b) in the dark. A layout of wells (c): control wells A1, B1, and C1—untreated culture of Trichophyton rubrum; the remainder—agar medium with applied glycerol/water solutions of RB, urea, and thiourea at concentrations specified in the scheme.
Pathogens 10 00263 g010
Pathogens 10 00263 g011 550
Figure 11. UV-visible absorption spectra of the urea solution (a) and the formulation containing RB, urea, and thiourea (b) in a glycerol/water (70/30%, w/w) solution before (blue line) and after 32 days of incubation (black dotted line) at 30 °C in the dark.
Figure 11. UV-visible absorption spectra of the urea solution (a) and the formulation containing RB, urea, and thiourea (b) in a glycerol/water (70/30%, w/w) solution before (blue line) and after 32 days of incubation (black dotted line) at 30 °C in the dark.
Pathogens 10 00263 g011
Pathogens 10 00263 sch001 550
Scheme 1. General presentation of the experiment on the photodynamic treatment of Trichophyton rubrum.
Scheme 1. General presentation of the experiment on the photodynamic treatment of Trichophyton rubrum.
Pathogens 10 00263 sch001
Table
Table 1. Composition and wavelengths of maximal absorption (λmax) of samples in experiments for testing stability of formulations.
Table 1. Composition and wavelengths of maximal absorption (λmax) of samples in experiments for testing stability of formulations.
SolventSample NumberUrea (g)Thiourea (g)Rose Bengal (g)λmax (nm)
Water 110.1 190
2 0.1 196, 236
3 0.1212, 546
40.10.10.1230, 546
Glycerol/Water 1
70/30%, w/w		50.1 202
6 0.1 230
7 0.1214, 556
80.10.10.1230, 556
1 Components were dissolved in 10 mL of the solvent.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Valkov, A.; Zinigrad, M.; Nisnevitch, M. Photodynamic Eradication of Trichophyton rubrum and Candida albicans. Pathogens 2021, 10, 263. https://doi.org/10.3390/pathogens10030263

AMA Style

Valkov A, Zinigrad M, Nisnevitch M. Photodynamic Eradication of Trichophyton rubrum and Candida albicans. Pathogens. 2021; 10(3):263. https://doi.org/10.3390/pathogens10030263

Chicago/Turabian Style

Valkov, Anton, Michael Zinigrad, and Marina Nisnevitch. 2021. "Photodynamic Eradication of Trichophyton rubrum and Candida albicans" Pathogens 10, no. 3: 263. https://doi.org/10.3390/pathogens10030263

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop